Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol Levels

NCT00216463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo

Sponsor

Kastle Therapeutics, LLC

Collaborators

[object Object]